Pulmonary Disorders and COVID-19

Jump to navigation Jump to search

To go to the COVID-19 project topics list, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Covid-19 infection is associated with pulmonary complications such as acute respiratory distress syndrome, pneumonia, pulmonary embolism, hypoxemia, superinfection, respiratory failure, and increased mortality in patients with an underlying pulmonary disease such as chronic obstructive pulmonary disease (COPD).

Complications

Acute respiratory distress syndrome

Pneumonia

Pulmonary embolism

Hypoxemia

Superinfection

Respiratory failure

Increased mortality in COPD patients

  • According to a study conducted in China, having an underlying comorbidity such as chronic obstructive pulmonary disease (COPD) conferred a mortality hazard ratio of 2.681, even after adjusting for smoking status.[1][2][3][4]

References

  1. ↑ Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM; et al. (2020). "Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis". Eur Respir J. 55 (5). doi:10.1183/13993003.00547-2020. PMC 7098485 Check |pmc= value (help). PMID 32217650 Check |pmid= value (help).
  2. ↑ https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184
  3. ↑ https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184
  4. ↑ Ñamendys-Silva SA (2020). "Respiratory support for patients with COVID-19 infection". Lancet Respir Med. 8 (4): e18. doi:10.1016/S2213-2600(20)30110-7. PMC 7129706 Check |pmc= value (help). PMID 32145829 Check |pmid= value (help).
Retrieved from "https://www.wikidoc.org/index.php?title=Pulmonary_Disorders_and_COVID-19&oldid=1614643"